VNRX logo

VolitionRx Limited (VNRX) Company Overview

Profile

Full Name:

VolitionRx Limited

Sector:

Healthcare

Country:

United States

IPO:

March 2, 2012

Indexes:

Not included

Description:

VolitionRx Limited (VNRX) is a biotechnology company focused on developing blood-based diagnostic tests for cancer. Their innovative technology aims to detect various cancers early, improving patient outcomes. The company is dedicated to advancing healthcare through research and development of simple, accurate, and cost-effective diagnostic solutions.

Key Details

Price

$0.62

Annual Revenue

$775.30 K(+153.04% YoY)

Annual EPS

-$0.50(+9.09% YoY)

Annual ROE

452.68%

Beta

0.75

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 D. Boral Capital
Buy
Feb 6, 25 D. Boral Capital
Buy
Jan 29, 25 D. Boral Capital
Buy
Jan 8, 25 D. Boral Capital
Buy
Dec 10, 24 D. Boral Capital
Buy
Nov 22, 24 Benchmark
Hold
Nov 15, 24 D. Boral Capital
Buy
Nov 1, 24 EF Hutton
Buy
Aug 16, 24 Benchmark
Hold
Jun 7, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for VolitionRx Limited?
  • Does VolitionRx Limited pay dividends?
  • What sector is VolitionRx Limited in?
  • What industry is VolitionRx Limited in?
  • What country is VolitionRx Limited based in?
  • When did VolitionRx Limited go public?
  • Is VolitionRx Limited in the S&P 500?
  • Is VolitionRx Limited in the NASDAQ 100?
  • Is VolitionRx Limited in the Dow Jones?
  • When was VolitionRx Limited's last earnings report?
  • When does VolitionRx Limited report earnings?
  • Should I buy VolitionRx Limited stock now?

What is the ticker symbol for VolitionRx Limited?

The ticker symbol for VolitionRx Limited is NYSE American:VNRX

Does VolitionRx Limited pay dividends?

No, VolitionRx Limited does not pay dividends

What sector is VolitionRx Limited in?

VolitionRx Limited is in the Healthcare sector

What industry is VolitionRx Limited in?

VolitionRx Limited is in the Medical Devices industry

What country is VolitionRx Limited based in?

VolitionRx Limited is headquartered in United States

When did VolitionRx Limited go public?

VolitionRx Limited's initial public offering (IPO) was on March 2, 2012

Is VolitionRx Limited in the S&P 500?

No, VolitionRx Limited is not included in the S&P 500 index

Is VolitionRx Limited in the NASDAQ 100?

No, VolitionRx Limited is not included in the NASDAQ 100 index

Is VolitionRx Limited in the Dow Jones?

No, VolitionRx Limited is not included in the Dow Jones index

When was VolitionRx Limited's last earnings report?

VolitionRx Limited's most recent earnings report was on Nov 15, 2024

When does VolitionRx Limited report earnings?

The next expected earnings date for VolitionRx Limited is Mar 26, 2025

Should I buy VolitionRx Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions